Bayview Legacy, Llc Sells 192,686 Shares of Arteris (NASDAQ:AIP) Stock

Arteris, Inc. (NASDAQ:AIP) major shareholder Bayview Legacy, Llc sold 192,686 shares of the business’s stock in a transaction on Thursday, July 2nd. The stock was sold at an average price of $36.32, for a total transaction of $6,998,355.52. Following the completion of the transaction, the insider owned 8,555,047 shares of the company’s stock, valued at approximately $310,719,307.04. This trade represents a 2.20% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Large shareholders that own more than 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Bayview Legacy, Llc also recently made the following trade(s):

• On Monday, June 8th, Bayview Legacy, Llc sold 70,000 shares of Arteris stock. The shares were sold at an average price of $34.91, for a total value of $2,443,700.00.
• On Friday, May 8th, Bayview Legacy, Llc sold 70,000 shares of Arteris stock. The stock was sold at an average price of $31.20, for a total value of $2,184,000.00.
• On Wednesday, April 8th, Bayview Legacy, Llc sold 70,000 shares of Arteris stock. The shares were sold at an average price of $19.04, for a total value of $1,332,800.00.

Arteris Stock Performance

Shares of Arteris stock opened at $31.32 on Wednesday. The business has a 50-day simple moving average of $36.62 and a 200-day simple moving average of $23.79. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.73 and a current ratio of 0.73. Arteris, Inc. has a one year low of $8.42 and a one year high of $50.26. The company has a market cap of $1.45 billion, a PE ratio of -39.65 and a beta of 1.92.

Arteris (NASDAQ:AIP) last issued its quarterly earnings results on Tuesday, May 12th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.08) by $0.05. The firm had revenue of $22.94 million during the quarter, compared to analysts’ expectations of $21.03 million. On average, equities research analysts forecast that Arteris, Inc. will post -0.54 EPS for the current fiscal year.

Hedge Funds Weigh In On Arteris

Hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Needham Investment Management LLC lifted its position in shares of Arteris by 2.6% in the fourth quarter. Needham Investment Management LLC now owns 3,411,500 shares of the company’s stock valued at $52,878,000 after acquiring an additional 86,500 shares in the last quarter. Franklin Resources Inc. grew its holdings in Arteris by 6.2% in the fourth quarter. Franklin Resources Inc. now owns 1,743,031 shares of the company’s stock valued at $27,017,000 after purchasing an additional 101,646 shares during the period. Vanguard Group Inc. boosted its holdings in Arteris by 8.2% in the third quarter. Vanguard Group Inc. now owns 1,594,402 shares of the company’s stock valued at $16,103,000 after acquiring an additional 120,947 shares during the last quarter. Westerly Capital Management LLC grew its holdings in shares of Arteris by 109.6% during the 3rd quarter. Westerly Capital Management LLC now owns 1,425,000 shares of the company’s stock worth $14,392,000 after purchasing an additional 745,000 shares during the period. Finally, Goldman Sachs Group Inc. increased its position in shares of Arteris by 144.7% in the fourth quarter. Goldman Sachs Group Inc. now owns 1,012,670 shares of the company’s stock worth $15,696,000 after acquiring an additional 598,840 shares in the last quarter. Institutional investors and hedge funds own 64.36% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have weighed in on AIP shares. Northland Securities set a $38.00 price target on Arteris in a research note on Wednesday, May 13th. TD Cowen increased their price objective on Arteris from $22.00 to $40.00 and gave the company a “buy” rating in a report on Wednesday, May 13th. Wall Street Zen cut Arteris from a “buy” rating to a “hold” rating in a research note on Saturday, May 2nd. Rosenblatt Securities boosted their price target on shares of Arteris from $20.00 to $38.00 and gave the company a “buy” rating in a research report on Wednesday, May 13th. Finally, Weiss Ratings lowered shares of Arteris from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Wednesday, May 13th. Two research analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and an average target price of $37.75.

Arteris News Summary

Here are the key news stories impacting Arteris this week:

• Neutral Sentiment: Several Arteris insiders disclosed planned share sales tied to equity vesting and tax withholding obligations, including CEO K. Charles Janac, CFO Nicholas B. Hawkins, COO Laurent R. Moll, and VP Paul Alpern. These trades can weigh on sentiment because they increase near-term selling pressure, but they were not described as discretionary bearish bets. Article Title
• Neutral Sentiment: Despite the insider sales, the transactions were largely routine: the company said the shares were sold to cover tax obligations related to vesting equity awards. That limits how negative investors may view the filings, since the sales do not necessarily signal a change in management’s outlook. Article Title
• Positive Sentiment: Arteris’ last quarterly report was stronger than expected, with earnings per share of -$0.03 versus estimates for -$0.08, and revenue of $22.94 million versus $21.03 million expected. That shows continued execution and may help cushion the stock if investors focus on fundamentals rather than insider activity.
• Positive Sentiment: Analyst sentiment is still supportive overall, with a consensus rating of “Hold” and an average price target around $37.75, while several firms recently lifted targets into the high-$30s to $40 range. That suggests the market still sees upside potential if growth continues.
• Negative Sentiment: The stock is also trading below recent levels after moving sharply lower, which may reflect a broader reassessment of valuation after a strong run and the recent insider selling headlines.

About Arteris

Arteris, Inc is a fabless semiconductor intellectual property (IP) company specializing in on-chip interconnect solutions and system IP for advanced integrated circuits. The company’s core products include its FlexNoC network-on-chip (NoC) fabrics, Ncore cache coherent interconnect IP, and CodaCache memory subsystem IP. These technologies enable semiconductor and systems companies to design scalable, energy-efficient chips for applications ranging from automotive and artificial intelligence (AI) to 5G communications and high-performance computing.

Founded in 2003 and headquartered in Santa Clara, California, Arteris serves a global customer base across North America, Europe, and Asia.